del.icio.us
Merck And GTx Go Their Separate Wayspublished Mon, Mar 15 2010 17:10 GMT
Pair will end partnership on cancer drug, leaving GTx with rights, and costs, of development.
Click for more articles from www.forbes.com
|
|